Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

6.920 -0.580 (-7.73%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Phathom Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Phathom Pharmaceuticals Q2 Earnings Call Highlights ↗

July 30, 2026

Phathom Pharmaceuticals (NASDAQ:PHAT) reported second-quarter 2026 revenue growth of 88% year over year and said it achieved positive operating profit excluding stock-based compensation for the first...

Via MarketBeat

Topics Earnings

Phathom Pharmaceuticals (PHAT) Falls After Cutting 2026 Revenue Guidance Despite Q2 Beat ↗

July 30, 2026

Via Chartmill

Phathom (PHAT) Q1 2026 Earnings Transcript ↗

April 30, 2026

Phathom (PHAT) Q1 2026 Earnings Transcript

Via The Motley Fool

Phathom Pharmaceuticals (NASDAQ:PHAT) Smashes Q1 Expectations, Nears Profitability Milestone ↗

April 30, 2026

Via Chartmill

Phathom (PHAT) Q4 2025 Earnings Call Transcript ↗

February 27, 2026

Phathom (PHAT) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Phathom Pharmaceuticals (NASDAQ:PHAT) Q4 2025 Earnings: Revenue Beat and Narrowed Losses Signal Path to Profitability ↗

February 26, 2026

Via Chartmill

Phathom Pharma Shows Sales Strength, Targets 2026 Profitability ↗

January 08, 2026

Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue guidance to $174.5-$175.5 million.

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

January 08, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

January 07, 2026

Via Chartmill

PHATHOM PHARMACEUTICALS INC (NASDAQ:PHAT) Shows Strong Growth and Momentum Alignment with Minervini Strategy ↗

December 13, 2025

PHAT stock aligns with the Minervini growth strategy, showing a strong technical uptrend and explosive 460% revenue growth, making it a high-potential momentum candidate.

Via Chartmill

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

High Growth Momentum and Technical Strength Drive PHATHOM PHARMACEUTICALS INC (NASDAQ:PHAT) ↗

November 14, 2025

Discover a powerful stock-picking strategy combining Minervini's Trend Template with High Growth Momentum to find high-potential stocks like PHAT.

Via Chartmill

Phathom Pharmaceuticals (NASDAQ:PHAT) Surpasses Q3 2025 Earnings Estimates and Raises Full-Year Guidance ↗

October 30, 2025

Phathom Pharma's Q3 2025 earnings beat expectations. Revenue hit $49.5M, and its EPS loss narrowed to $0.15. The company also raised its full-year 2025 revenue guidance.

Via Chartmill

Topics Earnings

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 01, 2025

Via Benzinga

Phathom (PHAT) Q2 Revenue Jumps 441% ↗

August 07, 2025

Via The Motley Fool

Phathom Pharmaceuticals (NASDAQ:PHAT) Surpasses Q2 Estimates with Strong VOQUEZNA Growth, Shares Jump 6% in Premarket ↗

August 07, 2025

Phathom Pharmaceuticals (PHAT) beats Q2 revenue and EPS estimates, driven by strong VOQUEZNA adoption. Shares rise 6.2% premarket as company narrows losses and raises full-year guidance.

Via Chartmill

Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday ↗

June 13, 2025

Via Benzinga

Phathom Pharmaceuticals Stock Doubles After FDA Grants Full 10-Year Exclusivity For Voquezna ↗

June 06, 2025

Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) shares are trading lower Friday after the company announced a major regulatory win.

Via Benzinga

Which stocks are moving on Friday? ↗

June 06, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 06, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

June 06, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Palo Alto Networks, Take-Two Interactive Software, VF Corp And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

May 21, 2025

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

May 16, 2025

Via Benzinga

Top movers in Friday's session ↗

May 09, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Keep an eye on the top gainers and losers in Friday's session. ↗

May 09, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 09, 2025

Via Benzinga

Retail Interest in Phathom Soars As Firm Pledges Profit Path, Cuts Costs After Q1 Miss ↗

May 02, 2025

Phathom's VOQUEZNA prescriptions rose 8% sequentially in Q1, with over 390,000 cumulative fills and expanding adoption across both GI and primary care.

Via Stocktwits

Topics Intellectual Property

Here are the top movers in Thursday's session. ↗

May 01, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

Top stock movements in today's session. ↗

May 01, 2025

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.